Insider · CIK 0001134365
George Migausky V
Files at RGNX (REGENXBIO Inc.), IMVT (Immunovant, Inc.). First filing -, latest -.
George Migausky V files SEC Form 4 as director at RGNX (REGENXBIO Inc.), and also at IMVT (Immunovant, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; George Migausky V has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 21, 2025 | IMVT IMMUNOVANT, INC. | 21,812 0.01% of outstanding | $318k | May 21, 2025 | $411k |
| May 19, 2025 | IMVT IMMUNOVANT, INC. | 28,188 0.02% of outstanding | $411k | May 19, 2025 | none |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +9,807 | $0.00 | $0 | 28,861 | Jun 2, 2026 |
| May 29, 2026 | RGNX REGENXBIO Inc. | AGrant or award Stock Options (Right to Buy)derivative | +46,600 | $0.00 | $0 | 46,600 | Jun 2, 2026 |
| May 30, 2025 | RGNX REGENXBIO Inc. | AGrant or award Common Stock | +7,768 | $0.00 | $0 | 19,054 | Jun 3, 2025 |
| May 30, 2025 | RGNX REGENXBIO Inc. | AGrant or award Stock Options (Right to Buy)derivative | +39,815 | $0.00 | $0 | 39,815 | Jun 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +16,188 | $0.00 | $0 | 137,251 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +7,600 | $0.00 | $0 | 7,600 | Apr 3, 2025 |
Questions about George Migausky V
Answered from the filings on this page, as of the latest one.
Is George Migausky V buying or selling?
George Migausky V has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did George Migausky V's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and George Migausky V has 0.
Where does George Migausky V file Form 4?
George Migausky V has filed Form 4 at RGNX (REGENXBIO Inc.); IMVT (Immunovant, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.